A research study of a new combination antibiotic is now underway for people suffering from Crohn’s disease.
The main purpose of this Ménière’s disease study is to see if the investigational drug reduces the number of vertigo episodes that patients endure.
The Marco Clinical Research Study is for children ages 6 – 17 who have Functional Constipation (FC). The Polo Clinical Research Study is for children ages 7 – 17 who suffer from Irritable Bowel Syndrome with Constipation or IBS-C.
NOURISH AD is a clinical research study evaluating the safety and effectiveness of an investigational drug for mild to moderate Alzheimer’s disease. Study volunteers will be monitored closely by their study doctor. To see if your loved one qualifies, call 1-888-400-4040
The Face It Acne Research Studies measure and evaluate the effectiveness of the reduction of inflammatory facial acne lesions through the means of a topical solution and pulsed laser. Males and females, ages 12 or older, with moderate to severe facial acne, will participate in the studies.
MINDSET is a Phase III clinical research program evaluating an investigational medication, RVT-101, for mild-to-moderate Alzheimer's disease. Researchers are investigating how effective RVT-101 in combination with donepezil (sometimes known as Aricept®) will be in helping with patients' cognition and ability to perform daily living activities, as compared with donepezil alone. Are you or a loved one interested in participating in MINDSET? Call 877-311-1977
The CRIB and CRADLE research studies are for women who have decided to start or continue taking Certolizumab Pegol (Cimzia®) while pregnant or breastfeeding. The studies are evaluating the transfer of this medication from mother to infant.
The Brocade3 study is a research study evaluating the safety and effectiveness of an investigational, oral medication in addition to treatment with chemotherapy for patients with metastatic or locally advanced BRCA-associated breast cancer.
AMBAR is a clinical research study that looks at using an experimental plasma exchange as a possible future procedure for Alzheimer's disease. The study will look at the safety and effectiveness of using albumin, the investigational drug, in patients with mild-to-moderate Alzheimer’s disease. Call 1-877-746-1231
MyClinicalTrial.com is dedicated to providing comprehensive resources for potential Volunteers, Investigator sites, Sponsors/CROs. The purpose of the site is to increase awareness of clinical trials and to provide the industry standard for clinical trial enrollment services.